World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT01657175
Date of registration: 29/06/2012
Prospective Registration: No
Primary sponsor: Region Skane
Public title: Quality of Life After Oesophageal or Gastric Cancer Surgery
Scientific title: Quality of Life and Supportive Care Needs After Oesophageal or Gastric Cancer Surgery.
Date of first enrolment: January 2009
Target sample size: 82
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01657175
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Care Provider).  
Phase:  N/A
Countries of recruitment
Sweden
Contacts
Name:     Jan Johansson, MD PHD
Address: 
Telephone:
Email:
Affiliation:  Department of surgery, Skåne university hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with any stage tumours in the distal third of the oesophagus including type
II tumours at the gastro-oesophageal junction

- Transthoracic oesophageal resection with gastric tube reconstructions and circular
stapled anastomoses in the upper right chest Postoperative clinical courses without
complications, and postoperative anastomotic radiograms without anastomotic leakage

- Macro and microscopically tumour free upper resection margins Willingness, physical
and mental capability to comply with the result of the randomization, and ability to
follow the study protocol

- Adult >18 years

- Living in the southern of Sweden (Skåne county)

Exclusion Criteria:

- Preoperative or planned postoperative chemotherapy or radiotherapy to the tumour area
known at the time of discharge from the hospital.

- Postoperative need for continuous treatment with proton pump inhibitors (PPIs) or
histamine-2 blockers. Treatment with steroidal or non steroidal anti inflammatory
drugs other than occasionally

- Known allergy or side effects to PPIs preventing continuous treatment for one year

- Present drug or alcohol abuse

- Failure to attend at least one postoperative visit



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Oesophageal Cancer
Gastric Cancer
Quality of Life
Intervention(s)
Other: Supportive care
Primary Outcome(s)
Quality of Life [Time Frame: Change of QOL from discharge (discharge= approximately 2-4 weeks after surgery) to 6 months after discharge]
Secondary Outcome(s)
Contacts with the health care system [Time Frame: At dischage, 2 weeks, 2, 4 and 6 months after discharge.]
Satisfaction with care [Time Frame: At dischage, 2 weeks, 2, 4 and 6 months after discharge.]
sense of coherence (KASAM) [Time Frame: At dischage, 2 weeks, 2, 4 and 6 months after discharge.]
Informational need [Time Frame: At dischage, 2 weeks, 2, 4 and 6 months after discharge.]
Secondary ID(s)
2009 /117
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Skane University Hospital
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history